Pancreatic neuroendocrine neoplasms: survival trend analysis of a comprehensive center.

Coelho, Sara; Costa, Cláudia; Santos, Ana Paula; Souteiro, Pedro; Oliveira, Joana; Oliveira, Júlio; Azevedo, Isabel; Torres, Isabel; Bento, Maria José

Coelho, Sara; Costa, Cláudia; Santos, Ana Paula; Souteiro, Pedro; Oliveira, Joana; Oliveira, Júlio; Azevedo, Isabel; Torres, Isabel; Bento, Maria José.

Afiliación

Coelho S; Department of Medical Oncology, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.
Costa C; Department of Endocrinology, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.
Santos AP; Department of Endocrinology, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.
Souteiro P; Research Center, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.
Oliveira J; Department of Endocrinology, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.
Oliveira J; Department of Endocrinology, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.
Azevedo I; Department of Medical Oncology, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.
Torres I; Department of Medical Oncology, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.
Bento MJ; Department of Endocrinology, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal.

Endocr Oncol ; 2(1): 32-41, 2022 Jan.

Article en En | MEDLINE | ID: mdl-37435456

Palabras clave

neoplasm staging; neuroendocrine tumors; pancreatic cancer; prognostic factors; tumor grading

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Endocr Oncol Año: 2022 Tipo del documento: Article País de afiliación: Portugal

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google